On the clinical side, as a CRO and clinical data partner, IQVIA can access all Veeva applications for running trials, including study builds with Veeva EDC. This integration aims to simplify workflows ...

Mayo Clinic researchers have developed a new way to predict whether existing drugs could be repurposed to treat heart failure ...

A majority of cancer drugs approved in the US during 2019-2022 had “clinical trial uncertainties,” research suggests.

The CORE-MD (Coordinating Research and Evidence for high-risk Medical Devices) consortium has published new consensus ...

People who show signs of attention-deficit hyperactivity disorder tend to take greater financial risks when trading online, but these decisions may come at a cost. A new study published in Scientific ...

Asan Medical Center is a reference hospital and the teaching hospital of the University of Ulsan College of Medicine, located in Seoul, South Korea. With 2,432 beds for patients and a total floor area ...

ShiraTronics, Inc., a clinical-stage medical device company focused on developing novel neuromodulation therapies for chronic ...

Icotrokinra is a first-in-class investigational targeted oral peptide that selectively blocks the IL-23 receptor 1 Filing ...

A microsimulation model was used to evaluate the cost-effectiveness of two glucagon-like peptide-1 receptor agonists (GLP1RAs), semaglutide and tirzepatide, for patients with osteoarthritis and ...

Recently initiated Phase 1b/2 multiple ascending dose study intended to assess safety and efficacy in nAMD patients receiving four initial ...